Your Body Speaks. We Listen. Research Cooperation

Math Biology® pioneers DMA® (Deep Metabolic-process Assessment), a non-invasive, AI-based platform that turns the body's bioelectrical signals into structured metabolic information. A single visit measures up to 600 bio-parameters; our protocol library covers 1,500+ biomarkers and keeps expanding.

One technology, three regulatory grades:

• DMA® Performance – general wellness, for sport and longevity. Market ready.

• DMA® Screening – EU MDR Class I, auxiliary information for prevention and functional medicine. Completing Oct 2026, with ISO 13485.

• DMA® Diagnostics – EU MDR Class IIa, in development, advancing toward clinical-grade support for early diagnosis.

Sport and longevity generate cash-pay revenue today, independent of reimbursement, while clinical validation builds long-term value on the same data asset.

Evidence: retrospective concordance with third-party clinical diagnostics on (positive agreement >95%); 3 clinical studies ongoing with the University of Salerno and Campus Bio-Medico.

Delivered as Technology-as-a-Service through flagship Human Biology Institutes and franchise partner sites in clinics, pharmacies and performance centers, generating recurring revenue across the EU, US and UAE.
We are looking for cooperation in the different clinical (Chronic and rare diseases) area and translational medicine.